EMCDDA Home
  • EN
Search

Table TDI-8. Primary use of stimulants of clients entering treatment, 2011 or most recent year available

Part (i) New clients by country and type of stimulant (%)

CountryAmphetamines%Ecstasy%Other stimulants%Total stimulants
Belgium125089.6238.231.1279
Bulgaria583.3116.700.06
Czech Republic312299.830.130.13128
Denmark14995.574.500.0156
Germany2::::::2437
Estonia8100.0::::8
Ireland33354.12439.346.661
Greece216.7541.7541.712
Spain332078.06616.1245.9410
France3128.42422.05449.5109
Italy41612.210781.786.1131
Cyprus114.3114.3571.47
Latvia510496.300.043.7108
Lithuania2::::::5
Luxembourg0:::::0
Hungary35472.8387.89419.3486
Malta00.0337.5562.58
Netherlands49986.65810.1193.3576
Austria4859.31619.81721.081
Poland69695.011.044.0101
Portugal7114.3457.1228.67
Romania1058.8741.200.017
Slovenia150.0150.0::2
Slovakia40099.320.510.2403
Finland2982.925.7411.435
Sweden:::::::
United Kingdom8161560.51415.391334.22669
Croatia2562.5615.0922.540
Turkey990.0110.0::10
Norway:::::::
Total712863.15414.8117810.411292
 

Notes:

: Indicates no data available

Percentages are of clients in treatment for stimulants as primary drug

(1) In Belgium if the exact primary drug is not known, the generic category is recorded.

(2) For Germany and Lithuania only the aggregated data for Stimulants Total are available.

(3) Data are from 2010.

(4) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(5) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(6) Data from 2010. Category amphetamines includes both amphetamine and methamphetamine. Data presented in the table come from TDI pilot project.

(7) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 onwards data with previous years.

(8) Data are from 1st of April 2010 to 31st March 2011.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Standard table 3.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013